期刊文献+

完全性大动脉转位手术中应用康斯特保护液的心肌保护效果观察 被引量:1

暂未订购
导出
摘要 目的:观察康斯特保护液(HTK液)对心脏手术中长时间缺血心肌的术后影响。方法:28例完全性大动脉转位手术患者随机分为两组。HTK液组灌注HTK液,St.Thomas液组灌注冷血停搏液。两组分别于送返ICU后1h取静脉血3mL,行心肌肌钙蛋白、肌酸激酶同工酶、血肌红蛋白检测。并记录临床效果观察指标:体外循环停止时正性肌力药评分、术后留置气管导管时间、ICU治疗时间、死亡率。结果:两组病例术后各项生化检测指标差异均无显著性(P>0.05);且体外循环停止时正性肌力药评分、术后留置气管导管时间、ICU治疗时间、死亡率差异亦无显著性(P>0.05)。结论:在需长时间阻断的新生儿和婴幼儿心脏手术中,HTK液和冷血停搏液对术后的影响无明显差异。
作者 熊德生
出处 《实用医学杂志》 CAS 北大核心 2012年第19期3240-3242,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献6

  • 1Ihnken K. Myocardial protection in hypoxic immature hearts [J]. Thorac Cardiov Surg, 2000, 48( 1 ) :46-54.
  • 2Xia Y, Warshaw J W, Haddad G G. Effect of chronic hypoxia on glucose transporters in heart and skeletal muscle of immature and adult adult rats [J]. Am J Physiol,1997,273 (5 Pt 2): R1734-1741.
  • 3Careaga G, Salazar D, Tellez S, et al. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients [J]. Arch Med Res, 2001,32(4): 296-299.
  • 4Sakata J, Morishita K, Ito T, et al. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement [ J ]. J Card Surg , 1998,13 ( 1 ) : 43-47.
  • 5宋怡,李华,杨鸿生,张桂敏,蔡冰.康斯特保护液对紫绀型先天性心脏病未成熟心肌保护效果的临床研究[J].中国体外循环杂志,2009,7(1):23-25. 被引量:11
  • 6冯正义,刘晋萍,赵举,李波,龙村.HTK和St. Thomas液在复杂先天性心脏病长时间心肌缺血心肺转流中的应用[J].临床麻醉学杂志,2009,25(10):833-835. 被引量:8

二级参考文献15

  • 1李桂芬,王仕刚,胡强,刘迎龙,龙村,赵红.康斯特保护液对未成熟心肌保护效果的临床观察[J].中国体外循环杂志,2006,4(1):9-11. 被引量:15
  • 2唐红.超声心动图对心功能的评估[J].中国胸心血管外科临床杂志,2006,13(3):210-212. 被引量:8
  • 3Flameng W,Borgers M,Daenen W,et al.Ultrastructrual and cytochemical correlates of myocardial protection by cardiac hypothermia in man[J].J thorac cardiovasc surg,1980,79(3):413-424.
  • 4Bull C,Cooper J,Stark J.Cardioplegic protection of the child's heart[J].J Thorac Cardiovasc Surg,1984,88(2):287-293.
  • 5Murashita T,Keishu.Y.Comparison of the properties of St.Thoms,Tyers and Bretshneider's cardioplegic solutions in the neonatal rabbit heart[J].J Jpn assoc thorac surg,1996,44:2027-2031.
  • 6Taggart DP, Hadjinikolas L, Hooper J, et al. Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations. J Thorac Cardiovasc Surg, 1997,113:728-735.
  • 7Krohn E,Stinner B,Fleckenstein M,et al. The cardioplegic solution HTK: effects on membrane potential, intracellular K^+ and Na^+ activities in sheep cardiac Purkinje fibres. Pflugers Arch, 1989,415 : 269-275.
  • 8Castaneda AR,Jonas RA, Mayer JE, et al. Myocardial preservation in the immature heart. Cardiac Surgery of the neonate and infant. Philadelphia :WB Sauuders, 1994:41-54.
  • 9Ibrahim MF, Venn GE, Young CP, et al. A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution. Eur J Cardiothorae Surg, 1999, 15: 75- 83.
  • 10Liu J, Feng Z, Zhao J, et al. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J,2008,54:470-473.

共引文献17

同被引文献5

  • 1李军,洪梅,潘铁成.体外循环中炎症因子释放对单核细胞促凝活性的影响[J].中华实验外科杂志,2006,23(11):1331-1333. 被引量:5
  • 2Yu JB, Gong LR, Wang J, et al. Effect of sevoflurane combination with epidural anesthesia on myocardial injury in patients with coronary artery disease undergoing non-cardiac surgery[J]. Saudi Med J, 2011, 32( 10): 1009-1016.
  • 3Ceyhan D, Tanriverdi B, Bilir A, et al. Comparison of the effects of sevoflurane and isoflurane on myocardial protection in coronary bypass surgery-Original Investigation [J]. Anadolu Kardiyol Derg, 2011, 11 (3) : 257 -262.
  • 4Casanova J, Garntti I, Simon C, et al. The effects of anesthetic preconditioning with sevoflurane in an experimental lung autotransplant model in pigs [J]. Anesth Analg, 2011, 113 (4) : 742-748.
  • 5毛倩倩,邹俊,张中军.七氟烷后处理对40例患者体外循环下肺静脉炎症因子的影响[J].重庆医学,2012,41(19):1975-1976. 被引量:4

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部